Ensoma has emerged with $70m in series A financing to advance research from Fred Hutchinson and University of Washington.

The vehicle charging technology developer, spun out of UC Irvine, has now raised $191m in total.

UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.

Osage University Partners has contributed to an oversubscribed series C round for Cyteir, which was led by RA Capital.

Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.

Today's deal net contains news from Boston Metal, Evologic Therapeutics, Lilz, GaitQ, Hemerion Therapeutics and Rebrain.

Cambridge and CRUK spinout Inivata has more than doubled its series C round to $60m following a $35m extension backed by IP Group.

Harvard-founded Nuvalent lured funding from Deerfield to debut with two assets devoted to overcoming kinase-driven resistance to non-small cell lung cancer.

Retail brand management business Soci has assembled $115m to date from investors including Stanford University's Daper Fund.

Northpond and Deerfield have co-led a $75m series C round for Encodia, seemingly the first publicly disclosed funding for the WashU spinout.